CONSULTATION OBJECTIVE: The emergency department attended the emergency department for 14 months, 15-03-20, due to respiratory distress.
• You have had a catarrhal syndrome for a week with associated bronchospasm in treatment with salbutamol 4 puff every 8 hours.
Feel increased difficulty in the last hours.
CONSULTATION OBJECTIVE • A 37.7oC fever with an isolated fever peak of 38oC in the last 48 h. Some vomiting of mucous content triggered by cough.
Normal stools
• Health map in isolation by direct contact with COVID-19.
ANESTHETIC DISEASE PERFORMERS
Normal neonatal period.
• Assignment by virus in treatment with albuterol on demand.
PHYSICAL EXPLORATION • Sat is found on arrival in the emergency department.
86% O2, along with tachypnea and universal stripping.
Ta 37,5oC.
• Acceptable general condition.
Skin and mucosal color was normal.
Do not exanthema or petechiae.
• PA: Acceptable bilateral air entry with ̈Cronchospasms ̈.
• Normal physical examination.
Bone-sided interstitial infiltrated TABLETS X-ray
Retrocardiac alveolar infiltrate.
Free costophrenic sinuses.
• Gases: pH 7.36, pCO2 40.4 mmHg, O2 40.9 mmHg, bicarbonate 22.7 mmol/L, Exc -2.4 • CRP Venous Base Virus NEGATIVA
• PCR VRS: POSITIVA For epidemic season COVID-19 and mother in contact with positive patient, PCR SARS-CoV-2 is requested.
EVOLUTION • Once you arrive, you are given conservative treatment with mask ventilation at a flow rate of 8 bpm (FiO2 31%), as well as bronchodilator treatment (Salbutamol + Bromurosol)
• Hospitalization was decided when complementary antibiotic therapy was required due to persistent hypoxemia.
• On admission, an ordinary laboratory test showed mild leukocytosis 11310N 4160L), CRP: 8.7 mg/L, LDH 284, CK 49, GPT 12, glucose 116 and urea 31.
During the first 24 hours, a NEGATIVO PCR result for SARS-CoV-2 was obtained.
• During admission, the patient remains in a descending position, being treated with ampicillin 200mg/kg/day due to an infiltrate in the middle lobe, as well as bronchodilator tto (Salbutamol and Bromuro) i
• High-flow physiotherapy (maximum 12 l.p.m. with FiO2 55%) is required to maintain a narrowing position, which can be progressively reduced until 48 h before discharge.
The patient was discharged on the third day of admission due to good evolution.
DIAGNOSIS • Moderate asthmatic crisis secondary to RSV infection.
•▁Pneumonia, MDS.
TREATMENT • Salbutamol, with a specially designed chamber and mask, on demand.
• Paracetamol, if you have a fever.
• Amoxicillin 80mg/kg/day until 7 days of treatment are completed.
• Alarm guidelines and information sheet of recommendations are given.
• The primary care paediatrician indicates follow-up by telephone of the disease evolution.
